Enhanced Expression of Nicotinamide N-Methyltransferase in Human Papillary Thyroid Carcinoma Cells

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4990-4996

  Xu, Jimin ^a   Moatamed, Farhad ^a   Caldwell, Jeremy S ^b   Walker, John R ^b   Kraiem, Zaki ^c   Taki, Katsumi ^a   Brent, Gregory A ^a   Hershman, Jerome M ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Genomics Novartis Foundation   (United States)

^c CARMEL MEDICAL CENTER   (Israel)

^d Vet Aff Gtr Los Angeles H   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; NICOTINAMIDE METHYLTRANSFERASE; TUMOR MARKER;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METHYLATION; NICOTINAMIDE N METHYLTRANSFERASE GENE; NORTHERN BLOTTING; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

BLOTTING, NORTHERN; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY, FOLLICULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; METHYLTRANSFERASES; NICOTINAMIDE N-METHYLTRANSFERASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0242383313     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021843     Document Type: Article

References (45)

1. Gimm O 2001 Thyroid cancer. Cancer Lett 163:143-156
2. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89:202-217
3. Dulgeroff AJ, Hershman JM 1995 Medical therapy for differentiated thyroid carcinoma. Endocr Rev 15:500-515
4. Ain KB 1998 Anaplastic thyroid carcinoma: behaivor, biology and therapeutic approaches. Thyroid 8:715-726
5. Alston TA, Abeles RH 1988 Substrate specificity of nicotinamide methyltransferase isolated from porcine liver. Arch Biochem Biophys 260:601-608
6. Aoyama K, Matsubara K, Kondo M, Murakawa Y, Suno M, Yamashita K, Yamaguchi S, Kobayashi S 2001 Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurosci Lett 298:78-80
7. Fukushima T, Kaetsu A, Lim H, Moriyama M 2002 Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp Toxicol Pathol 53:469-473
8. Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB 2002 Expression of nicotinamide N-methyltransferase (E. C. 2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol 61:111-124
9. Parsons RB, Smith SW, Waring RH, Williams AC, Ramsden DB 2003 High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease. Neurosci Lett 342:13-16
10. Kassem HSh, Sangar V, Cowan R, Clarke N, Margison GP 2002 A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer 101:454-460
11. Ohta K, Pang XP, Berg L, Hershman JM 1997 Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the β-adrenergic receptor. J Clin Endocrinol Metab 82:2633-2638
12. Schonberger J, Bauer J, Spruss T, Weber G, Chahoud I, Eilles C, Grimm D 2000 Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78:102-110
13. Soh EY, Sobhi SA, Wong MG, Meng YG, Siperstein AE, Clark OH, Duh QY 1996 Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery 120:944-947
14. 1 integrins and production of proteases. World J Surg 16:770-776
15. Kraiem Z, Sadeh O, Heinrich R 2000 Preparation and culture of a serum-free human thyroid follicle system and its application for measuring thyroid hormone secretion, iodide uptake and organification, cyclic adenosine monophosphate formation, gene expression, and cell growth. Thyroid 10:53-57
16. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH 1990 Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 87:1663-1667
17. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ 1999 High density synthetic oligonucleotide arrays. Nat Genet 21:20-24
18. Lockhart DJ, Dong H, Byrne MC, Follettie KT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL 1996 Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680
19. Wodicka L, Dong H, Mittmann M, Ho M-H, Lockhart DJ 1997 Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 15:1359-1367
20. Southern E, Mir K, Shchepinov M 1999 Molecular interactions on microarrays. Nat Genet 21:5-9
21. Sambrook J, Russell D 2001 Molecular cloning: a laboratory manual, 3rd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
22. Rini J, Szumlanski C, Guerciolini R, Weinshilboum RM 1989 Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation. Clin Chim Acta 186:359-374
23. Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES 1999 Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anticancer Res 19:925-931
24. Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, Renner S, Livingston EH 2001 Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule. Surgery 130:834-843
25. Sugawara M, Matsuzuka F, Fukata S, Kuma K, Moatamed F, Haugen BR 2002 Excessive survivin expression in thyroid lymphomas. Hum Pathol 33:524-527
26. Kashima K, Yokoyama S, Daa T, Nakayama I, Nickerson PA, Noguchi S 1997 Cytoplasmic biotin-like activity interferes with immunohistochemical analysis of thyroid lesions: a comparison of antigen retrieval methods. Mod Pathol 10:515-519
27. Aksoy S, Szumlanski CL, Weinshilboum RM 1994 Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem 269:14835-14840
28. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044-15049
29. Seifert R, Hoshino J, Kroger H 1984 Nicotinamide methylation. Tissue distribution, developmental and neoplastic changes. Biochim Biophys Acta 801: 259-264
30. Li K, Prow T, Lemon SM, Beard MR 2002 Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35:1237-1246
31. Hanazawa Y, Sato K, Kuroiwa N, Ogawa M, Kuriyama A, Asanagi M, Kato N, Moriyama Y, Horitsu K, Fujimura S 1994 Characterization of nicotinamide methyltransferase in livers of mice bearing Ehrlich ascites tumors: preferential increase of activity. Tumour Biol 15:7-16
32. 1-Methylnicotinamide level in the blood after nicotinamide loading as further evidence for malignant tumor burden. Jpn J Cancer Res 82:1277-1283
33. Okamura A, Ohmura Y, Islam MM, Tagawa M, Horitsu K, Moriyama Y, Fujimura S 1998 Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma. Jpn J Cancer Res 89:649-656
34. 1-methyl-nicotinamide oxidase activities in the livers of the rats administered alkylating agents. Cancer Lett 21:175-181
35. Hoshino J, Kuhne U, Kroger H 1982 Methylation of nicotinamide in rat liver cytosol and its correlation with hepatocellular proliferation. Biochim Biophys Acta 719:518-526
36. Smith ML, Burnett D, Bennett P, Waring RH, Brown HM, Williams AC, Ramsden DB 1998 A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol. Biochim Biophys Acta 1442:238-244
37. Jhiang SM 2000 The RET proto-oncogene in human cancers. Oncogene 19: 5590-5597
38. Nikiforov YE 2002 RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3-16
39. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G 2002 Molecular mechanisms of RET activation inhuman cancer. Ann NY Acad Sci 963:116-121
40. Tallini G, Asa SL 2001 RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 8:345-354
41. Basolo F, Giannini R, Toniolo A, Casalone R, Nikiforova M, Pacini F, Elisei R, Miccoli P, Berti P, Faviana P, Fiore L, Monaco C, Pierantoni GM, Fedele M, Nikiforov YE, Santoro M, Fusco A 2002 Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement. Int J Cancer 97:608-614
42. Califano D, Monaco C, de Vita G, D'Alessio A, Dathan NA, Possenti R, Vecchio G, Fusco A, Santoro M, and de Franciscis V 1995 Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. Oncogene 11:107-112
43. Xing S, Furminger TL, Tong Q, Jhiang SM 1998 Signal transduction pathways activated by RET oncoproteins in PC12 pheochromocytoma cells. J Biol Chem 273:4909-4914
44. Gharib H, Goellner JR 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289
45. Hershman JM, Blahd WH, Gordon HE 2001 Thyroid gland. In: Haskell CM, ed. Cancer treatment, 5th Ed. Philadelphia: Saunders; 1054-1064